431 related articles for article (PubMed ID: 7770998)
1. Flow cytometric DNA/cytokeratin analysis of bladder lavage: methodical aspects and clinical implications.
Liedl T
Urol Int; 1995; 54(1):22-47. PubMed ID: 7770998
[TBL] [Abstract][Full Text] [Related]
2. [Flow cytometric DNA analysis and cytology in diagnosis and prognosis of bladder tumors: preliminary results of a comparative study of bladder lavage].
Bellaoui H; Chefchaouni MC; Lazrak N; Khalfaoui LC; Yassine F; Elhamany Z
Ann Urol (Paris); 2002 Jan; 36(1):45-52. PubMed ID: 11859578
[TBL] [Abstract][Full Text] [Related]
3. [The clinical significance of flow cytometric DNA measurement of paraffin specimen in bladder tumor].
Wang Z
Zhonghua Wai Ke Za Zhi; 1990 Aug; 28(8):505-8, 512. PubMed ID: 2086120
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of urinary cytology, and deoxyribonucleic acid flow cytometry and cytology on bladder washings during followup for bladder tumors.
Grégoire M; Fradet Y; Meyer F; Têtu B; Bois R; Bédard G; Charrois R; Naud A
J Urol; 1997 May; 157(5):1660-4. PubMed ID: 9112500
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases.
Bakhos R; Shankey TV; Flanigan RC; Fisher S; Wojcik EM
Diagn Cytopathol; 2000 Feb; 22(2):65-9. PubMed ID: 10649514
[TBL] [Abstract][Full Text] [Related]
6. Clinical significance of flow cytometric deoxyribonucleic acid measurements of deparaffinized specimens in bladder tumors.
Miao T; Wang Z; Sang N; Xiong R; Cao S
Eur Urol; 1992; 21(2):98-102. PubMed ID: 1499623
[TBL] [Abstract][Full Text] [Related]
7. Characterization of squamous cell bladder tumors by flow cytometric deoxyribonucleic acid analysis: a report of 100 cases.
Shaaban AA; Tribukait B; el-Bedeiwy AF; Ghoneim MA
J Urol; 1990 Oct; 144(4):879-83. PubMed ID: 2398562
[TBL] [Abstract][Full Text] [Related]
8. [Contribution of cell cycle and DNA content study by flow cytometry in the prognosis of superficial bladder cancer: Tunisian experience].
Bounemra-Benghanem A; Amri MA; Rammeh-Rommani S; Chebil M; Zermani R; Ben Jilani S; Jenhani F
Ann Biol Clin (Paris); 2007; 65(1):41-9. PubMed ID: 17264038
[TBL] [Abstract][Full Text] [Related]
9. Prediction of recurrence and progression in primary superficial bladder cancer with DNA flow cytometry.
Saracino GA; Ditonno P; Disabato G; Traficante A; Battaglia M; Lucivero G; Selvaggi FP
Eur Urol; 1992; 21 Suppl 1():26-30. PubMed ID: 1425834
[TBL] [Abstract][Full Text] [Related]
10. Multiparameter flow cytometry for simultaneous assessment of p53 protein expression and cellular DNA content in oral squamous cell carcinomas: evidence for the development of aneuploid clones from p53-deficient diploid progenitor cells.
Hemmer J; Polackova J
Int J Oncol; 2000 Nov; 17(5):933-7. PubMed ID: 11029495
[TBL] [Abstract][Full Text] [Related]
11. Flow cytometry versus urinary cytology in the evaluation of patients with bladder cancer.
Murphy WM; Emerson LD; Chandler RW; Moinuddin SM; Soloway MS
J Urol; 1986 Oct; 136(4):815-9. PubMed ID: 3761437
[TBL] [Abstract][Full Text] [Related]
12. Clonal heterogeneity of aneuploid cell populations in carcinoma in situ of the bladder: a flow cytometric study.
Petersen SE; Harving N; Orntoft T; Wolf H
Scand J Urol Nephrol Suppl; 1988; 110():213-7. PubMed ID: 3187410
[No Abstract] [Full Text] [Related]
13. Cellular DNA content and proliferative activity evaluated by flow cytometry versus histopathological and staging classifications in human bladder tumors.
de Vita R; Forte D; Maggi F; Eleuteri P; Di Silverio F
Eur Urol; 1991; 19(1):65-73. PubMed ID: 2007422
[TBL] [Abstract][Full Text] [Related]
14. Primary invasive and in situ vaginal carcinoma. Flow cytometric analysis of DNA aneuploidy and cell proliferation from archival paraffin-embedded tissue.
Punnonen R; Kallioniemi OP; Mattila J; Väyrynen M; Koivula T
Eur J Obstet Gynecol Reprod Biol; 1989 Sep; 32(3):247-51. PubMed ID: 2792545
[TBL] [Abstract][Full Text] [Related]
15. Intratumoral heterogeneity in DNA ploidy of bladder carcinomas.
Sasaki K; Hamano K; Kinjo M; Hara S
Oncology; 1992; 49(3):219-22. PubMed ID: 1495749
[TBL] [Abstract][Full Text] [Related]
16. DNA-aneuploidy as marker for neoplasia in G1-urothelial carcinomas.
Planz B; Striepecke E; Wolff JM; Effert P; Jakse G; Böcking A
Gen Diagn Pathol; 1996 Oct; 142(2):69-73. PubMed ID: 8950570
[TBL] [Abstract][Full Text] [Related]
17. [Early diagnosis of bladder carcinoma].
Mantur M; Jakubowska I; Kemona H
Pol Merkur Lekarski; 2005 Feb; 18(104):173-5. PubMed ID: 17877124
[TBL] [Abstract][Full Text] [Related]
18. Acridine-orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder. The influence of prior local therapy.
Têtu B; Katz RL; Kalter SP; von Eschenbach AC; Barlogie B
Cancer; 1987 Oct; 60(8):1815-22. PubMed ID: 3652008
[TBL] [Abstract][Full Text] [Related]
19. Differential diagnosis and evaluation of the clinical course of transurethrally resected T1G3 urothelial carcinoma of the bladder by DNA image cytometry.
Biesterfeld S; Borchers H; Jellouschek H; Bono AV; Altwein JE; Algaba F; Jakse G
Anticancer Res; 2005; 25(5):3243-9. PubMed ID: 16101134
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of DNA content in human bladder tumors and irrigation fluids.
Chin JL; Huben RP; Nava E; Rustum YM; Greco JM; Pontes JE; Frankfurt OS
Cancer; 1985 Oct; 56(7):1677-81. PubMed ID: 4027899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
